Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
15351 participants
OBSERVATIONAL
2012-02-29
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To best of the investigators knowledge, there are no large scale European surveys estimating the prevalence of cardiac disease and associated clinical symptoms in a non-selected (non-athlete) population of this age group.
Purpose: To screen a young adult population from central regional of Portugal for heart disease possibly associated to a high risk of Sudden Cardiac Death (SCD).
To determine the national prevalence of clinical symptoms of heart disease and of heart disease with increased risk for SCD in this age group.
To detect young adults in risk of SCD and with an indication for evaluation by a cardiologist, and possible need of:
* medical treatment
* electrophysiologic (EP) study and percutaneous ablation
* an implantable cardiovertor defibrillator
* a pacemaker
* other type of specialized cardiac intervention
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Echocardiography and S' Wave for Early Recognition of Acute Coronary Syndrome in the Emergency Department, A Prospective Study
NCT06860997
Evaluation of Patients With Known or Suspected Heart Disease
NCT00001313
Developing a Brief Intervention to Communicate Cardiovascular Risk to Patients Presenting to the Emergency Department With Chest Pain: a Co-Production Approach. Phase 2.
NCT06903442
Left Ventricular Structural Predictors of Sudden Cardiac Death
NCT01076660
Development of an Evidenced-Based Tool for Prediction of Sudden Death in Patients With Non-Ischemic Cardiomyopathy
NCT02657967
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
young adults - Central region of Portugal
ECG and survey screening
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ECG and survey screening
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Providing an informed consent
12 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Unidade Local de Saúde de Coimbra, EPE
OTHER
Administração Regional de Saúde do Centro
OTHER
Medtronic
INDUSTRY
University of Coimbra
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rui Providência
M.D. M.Sc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rui Providência, M.D. M.Sc.
Role: STUDY_CHAIR
Coimbra's Hospital Centre and University; Faculty of Medicine, University of Coimbra, Portugal
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Unidade Móvel - Tenda de Rastreio - SCDSOS
Coimbra, State..., Portugal
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SCD-SOS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.